Home NDC 0143-9299 Ganciclovir
Product NDC 0143-9299
11-digit product format 001439299
Labeler code 0143
Product ID 0143-9299_192fd7cc-3a38-4afe-82f3-a4d89238b1ad
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ganciclovir sodium
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Hikma Pharmaceuticals USA Inc.
Application ANDA076222
Marketing category ANDA
Marketing start 2021-06-17
Substance GANCICLOVIR SODIUM
Active strength 50 mg/mL
Pharmacologic classes Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076222-001 GANCICLOVIR SODIUM GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A076222-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION 2003-07-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A076222-001 GANCICLOVIR SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 2003-07-16 cb3db0bc1861…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Ganciclovir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength GANCICLOVIR SODIUM 50 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 02L083W284 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 310442 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0143-9299-01 Ganciclovir 10 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 10 7 0143-9299-10 Ganciclovir 10 in 1 BOX INJECTION, POWDER, LYOPHILIZED, 10 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0143-9299 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] 7 Current NDC, Legacy NDC, 2 package rows 20250210_4f8219ca-6780-4131-8962-9c3fdd0a84dd.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0143-9299-01 00143929901 10 mL in 1 VIAL 10 ml Historical 0143-9299-10 00143929910 10 VIAL in 1 BOX (0143-9299-10) / 10 mL in 1 VIAL (0143-9299-01) 10 vial 2021-06-17 0000-00-00 No No Current